[elfsight_social_share_buttons id=”1″] Operation Warp Speed chief adviser Dr. Moncef Slaoui said the COVID-19 vaccine developed by British drugmaker AstraZeneca and Oxford University will likely be authorized for emergency use in the United States in April. Slaoui said recruitment for the British drugmaker’s late-stage U.S. trial is almost complete with over 29,000 participants enrolled. British regulators […]
- Categories:
- FISM News